Advertisements

Lizovag

Quick links to important sections

Lizovag

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Lizovag

What is Lizovag? A Foundational Overview

Lizovag is a dedicated antifungal agent defined by its single active component, Ketoconazole, which acts to halt the growth of various fungal organisms. This medication is classified as a synthetic compound belonging to the azole family of antimycotics, distinguishing its mechanism from antibiotics or simple topical treatments. Its general therapeutic purpose is to address microbial imbalances and pathological conditions caused by fungal proliferation in the body.


Quick Facts

Property Description
Active ingredient Ketoconazole
Form Tablet, Cream, Shampoo, Topical Solution
Pharmacological class Azole Antifungal / Antimycotic
Common purpose Inhibition and clearance of fungal infections
Origin Synthetic compound (Imidazole derivative)

What Type of Medicine is Lizovag and Its Primary Purpose?

Lizovag is an Azole Antifungal that utilizes the synthetic compound Ketoconazole to inhibit fungal growth and viability. This pharmacological classification is clinically recognized for its effectiveness against a wide spectrum of clinically relevant fungi. Ketoconazole is categorized as an essential medicine, affirming the drug's established therapeutic role in healthcare. The medicine's overall benefit stems from this core action, making it a treatment option for conditions where systemic or superficial fungal infections are present.

Composition, Forms, and Origin of Lizovag

As a synthetic derivative, the composition of Lizovag centers entirely on the Ketoconazole active ingredient, combined with pharmaceutical excipients that form the necessary vehicle. Ketoconazole is characterized as a broad-spectrum antifungal agent. Lizovag is made available in several dosage forms, including the Oral Tablet for systemic administration and localized preparations such as Cream, Shampoo, and Topical Solution. This range of forms allows the medicine to be applied via a Topical route for skin and scalp infections or taken Orally for internal challenges, depending on the specific product preparation.

How Does Lizovag Act on Fungi?

Lizovag's action is defined by its principle of ergosterol synthesis inhibition, which is the fundamental mechanism of the azole class. The medication works by structurally compromising the fungal cell membrane; it directly interferes with the production of ergosterol, an essential component that ensures the membrane's integrity. This antimycotic action is what ultimately prevents the fungus from replicating and surviving, resulting in its clearance by the body's defense systems.

Regulatory References

  1. World Health Organization (WHO)
Advertisements

What side effects are possible with Lizovag?

Possible Side Effects and Safety Information

Lizovag (Ketoconazole) is associated with an official safety profile that includes the risk of serious adverse reactions, which is why its oral use is restricted by regulatory authorities primarily to situations where other effective antifungal therapies are unavailable or not tolerated.

Adverse Reaction Scope and Classification

The most critical safety concern documented in regulatory labeling is Hepatotoxicity (liver damage), which can be severe, unpredictable in its onset, and has been reported in rare cases to necessitate liver transplantation or result in death. Other serious reactions include Adrenal Insufficiency, a hormonal imbalance, and the potential for life-threatening cardiac arrhythmias when co-administered with certain medications that affect heart rhythm.

The most frequently documented side effects, classified as Common in regulatory documents, typically involve the Gastrointestinal Disorders system, leading to nausea, vomiting, or abdominal pain. Other common effects include headache, pruritus (itching), asthenia (weakness/fatigue), and impotence. Less common effects officially documented across system-organ classes include dizziness, rash, alopecia, gynecomastia, and menstrual disorder.

Safety Restrictions and Population Considerations

Official labeling for oral use is highly restrictive: the medication is contraindicated in patients with pre-existing acute or chronic liver disease due to the elevated risk of hepatotoxicity. Furthermore, the label requires the mandatory monitoring of liver function tests (enzymes and bilirubin) both before starting treatment and frequently throughout therapy. The risk of serious adverse events associated with this medicine limits its therapeutic role as defined by governmental drug authorities.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Lizovag (Ketoconazole) defines specific manifestations that require immediate emergency intervention. Urgent medical help must be sought if overexposure results in severe acute symptoms such as collapse, a seizure, difficulty with trouble breathing, or if the person is unable to awaken. In any case of accidental overdose, the government-stated guidance requires calling the poison control helpline immediately.

Documented Overdose Manifestations and Risks

Official labeling describes overdose presentations linked to acute liver injury, which can include signs like anorexia, fatigue, nausea, and jaundice. The most severe consequences associated with toxic exposure involve the Hepatic and Cardiovascular systems. These serious outcomes include life-threatening ventricular dysrhythmias such as Torsades de pointes, and severe hepatotoxicity, which has been associated with fatal outcomes and the need for liver transplantation.

Official Emergency Management

No specific antidote is known for Lizovag overexposure; therefore, treatment consists of general supportive and symptomatic measures. Regulatory procedures specify that activated charcoal may be administered only within the first hour after acute ingestion. Monitoring requirements include continuous observation of the QTc interval via ECG and full sets of liver tests. Furthermore, specific management for high-dose exposure, such as adrenal insufficiency, involves administering hydrocortisone with saline and glucose infusion.

Advertisements

Therapeutic Uses of Lizovag

What Lizovag Treats: Main Uses and Benefits

Lizovag (Ketoconazole) is commonly used across domains where short-term symptom management is appropriate, with its role in managing symptoms and supporting functional stability across three main therapeutic areas.

Relief for Persistent Skin and Scalp Fungal Symptoms

This domain is used in situations involving certain distressing symptoms by addressing recurrent skin and scalp fungal manifestations, including dermatophytosis, yeast infections, and seborrheic dermatitis. Lizovag helps address symptom clusters that interfere with daily comfort, such as intense itching (pruritus), severe scaling and flaking, and the presence of discolored patches; its use contributes to improved comfort during periods of heightened symptoms. Topical forms of the medication are commonly used for managing infections caused by dermatophytes and yeasts.

“The primary benefit is restoring physical comfort and helping maintain functional stability during symptomatic episodes.”

Management of Serious Systemic Fungal Diseases

This medication is applied in clinical settings that involve acute or unstable symptom patterns for the management of serious systemic fungal infections when other suitable options are limited. Oral ketoconazole is indicated for the treatment of certain life-threatening fungal infections. These conditions, such as Histoplasmosis and Blastomycosis, are marked by symptoms related to systemic imbalance. The primary role is to contribute to managing symptoms and easing the overall symptom load, which may include symptoms related to systemic imbalance like persistent fever and debilitating fatigue associated with the infection.

Specialized Support for Endocrine Imbalance

In a distinct therapeutic context, Lizovag is applied across domains where additional symptomatic support is needed to manage the consequences of Endogenous Cushing's Syndrome. This use is relevant for easing symptoms related to heightened physiological activity associated with hypercortisolism, which may include supporting the management of blood pressure and blood glucose manifestations. It provides supportive relief when symptoms interfere with daily functioning and helps ease the overall symptom load.


Quick Fact: Relief for Skin and Systemic Symptoms

Lizovag is relevant in situations where symptoms cluster into patterns requiring supportive management, specifically addressing recurrent dermal discomfort (itching, scaling) and systemic instability (fever, fatigue) caused by fungal pathogens, as well as complex hormonal imbalance symptoms.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Lizovag? — Official Regulatory Information

Official regulatory documents define strict criteria for using Lizovag (oral ketoconazole). The medicine is generally designated for use in adults and adolescents aged 12 years and older.

Contraindications and Exclusions

Use of Lizovag is contraindicated (must not be used) in several specific patient groups:

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to the active substance or any other component (excipient) of the medicine.
  • Liver Disease: Patients with acute or chronic hepatic (liver) impairment are formally excluded due to the risk of serious liver injury.
  • Pre-treatment Liver Enzyme Levels: Treatment must not be initiated if the patient's liver enzyme levels are found to be above 2 times the upper limit of normal before starting the medicine.

Restricted Populations

  • Pediatrics: The medicine is not recommended for the pediatric population under 12 years of age, as safety and efficacy in this group have not been formally established.
  • Pregnancy/Lactation: Women of childbearing potential are required to use an effective method of contraception during treatment.

These official eligibility constraints emphasize a patient's liver health status and prior allergic history as mandatory determinants for who is able to safely receive the treatment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The official regulatory profile of Lizovag (Ketoconazole) is defined by its role as a strong inhibitor of the CYP3A4 enzyme, a documented pharmacokinetic interaction mechanism that leads to widespread drug interactions.

Specific interacting medicines are explicitly listed in government labeling as contraindicated combinations. These include Dofetilide, Quinidine, Pimozide, Methadone, Oral Midazolam, Simvastatin, Lovastatin, and Ergot Alkaloids. This strict classification is necessary to prevent severe outcomes such as life-threatening QTc prolongation, rhabdomyolysis, and enhanced sedation resulting from elevated plasma concentrations.

Interaction Constraints and Conditions

Absorption Dependence: The systemic exposure of Lizovag is reduced by acid-reducing agents (e.g., Proton Pump Inhibitors) due to its requirement for gastric acidity. Administration under conditions of reduced acidity may be addressed by administering the medicine with an acidic beverage.

Restriction on Co-administration: Co-administration with potent CYP3A4 inducers (e.g., Rifampin, Nevirapine) is restricted because it reduces Lizovag’s blood concentration and therapeutic efficacy. Furthermore, the use of oral Lizovag is formally contraindicated in patients with acute or chronic liver disease, and co-administration with alcohol consumption is restricted due to the increased risk of hepatotoxicity.

Advertisements

Mechanism of Action

Molecular Blockade of Fungal Sterol Production

The drug's primary action is the inhibition of the fungal enzyme Cytochrome P450 14alpha-demethylase (CYP51). By binding to this enzyme, the drug prevents the conversion of lanosterol into ergosterol, the primary sterol necessary for fungal cell membranes. This interaction initiates a cascading failure defined by metabolic disruption.


Cascade of Cell Membrane Structural Failure

The deficiency of functional ergosterol, coupled with the pathological buildup of toxic precursor sterols within the cell, structurally destabilizes the fungal cell membrane. This compromise leads to severe functional impairment, including loss of essential molecules and dysfunctional nutrient transport, which ultimately causes inhibition of cellular proliferation and compromises the ability of the fungal cell to maintain its structure.


Mechanistic Constraints and Off-Target Binding

The effectiveness of this mechanism is subject to biological constraints, such as the potential for fungal resistance through mutations in the CYP51 target or the action of efflux pumps that expel the drug. Structurally, the drug also has an affinity for certain mammalian P450 enzymes (CYP3A4), which is a separate consequence defined by the molecule's broad structural interaction with P450 systems.

Advertisements

Dosage and Administration Information

How to Use Lizovag: Official Administration Guidelines

The usage of Lizovag (Ketoconazole) is defined by its dosage form and administration route. The medicine is employed via the Oral route for systemic fungal conditions and through the Topical route for localized skin and scalp manifestations. The specific method, dose, and duration depend on the product formulation utilized.


Official Dosing and Frequency Patterns

Feature Guideline
Oral Tablet Dosing Standard adult starting dose is 200 mg once daily, which may be adjusted to 400 mg once daily. Pediatric dosing (aged 2 years and older) is determined by weight, typically 3.3 mg/kg to 6.6 mg/kg once daily.
Topical Frequency Applied once daily or twice daily depending on the specific condition, or as infrequently as twice weekly for maintenance phases (e.g., certain shampoo uses).

Key Administration Conditions

The Oral Tablet must be taken with a meal to optimize drug absorption. This requirement is due to the drug’s need for gastric acidity to dissolve. Topical preparations (creams, foams, shampoos) are for external use only and must not contact eyes or mucous membranes.

The course duration is determined by the specific use: superficial infections may require short-term use, such as two weeks for Tinea Versicolor, whereas systemic infections can require courses lasting up to six months. If a daily dose is missed, the instruction is to skip the missed dose and resume the regular schedule, rather than taking a double dose. Oral administration is not recommended for children under two years of age.

Advertisements

Recent Clinical Evidence

Research Evidence Overview for Lizovag


Evidence for use in Insomnia

Research has explored the use of Lizovag in studies involving adult populations where sleep-related outcomes were monitored. Studies relevant in trials assessing short-term or episodic symptom patterns primarily used randomized controlled trials (RCTs). These studies explored outcomes reflecting daily functioning by looking at patient-reported experiences such as how long it took participants to fall asleep (sleep latency) and the total time they spent asleep.

Some trials described patterns such as a shorter reported sleep latency when Lizovag was administered, compared to placebo. Studies also reported measurements of total sleep time that varied across trials. Studies also monitored observations related to changes in alertness, where drowsiness was observed in participants.

Long-term effects are not fully established concerning sleep quality or sustained patterns of use beyond two weeks. Sample sizes were modest, and the impact on objective sleep parameters was not well characterized compared to self-reported measures.


Evidence for use in Allergic Rhinitis (Seasonal/Perennial)

Lizovag was studied for outcomes related to inflammatory or irritative states linked to seasonal and perennial allergic rhinitis (hay fever). Research examined outcomes capturing phases of heightened symptom activity, such as sneezing, runny nose (rhinorrhea), and eye symptoms, primarily through RCTs.

The studies monitored patient-reported outcomes describing perceived discomfort. Studies report how symptoms evolved in the observed populations, where findings show patterns related to a reported decrease in some outcomes related to physical discomfort (such as sneezing and runny nose) in the short term. Studies monitored outcomes that included observations of changes in alertness.

Comparative evidence is lacking against other treatments. There is limited information for long-term outcomes regarding allergic rhinitis control or its impact on outcomes reflecting daily functioning.


What is still uncertain about Lizovag Research

The research so far contributes to the broader evidence landscape but leaves several gaps in the evidence. The certainty remains low in several areas, as sample sizes were modest and subgroup findings are uncertain across studies. A key uncertainty is the lack of long-term evidence, meaning limited information is available for long-term outcomes regarding patterns of observed changes. Data for certain groups remain insufficient, including children and individuals with existing medical conditions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lizovag (FAQ)


Q: Can Lizovag be split or crushed, or does it have to be swallowed whole?

Official drug administration information for the oral tablet specifies that it should be taken whole with a meal to ensure proper absorption. While some clinical situations, such as use in pediatric patients, may involve modified administration, specific regulatory instructions regarding crushing or splitting for general adult use are typically not provided on the label. Information regarding modified administration is typically part of the professional labeling.


Q: Does Lizovag interact with common pain relievers like ibuprofen or acetaminophen?

Lizovag oral tablets carry a documented risk of liver injury, known as hepatotoxicity. The official product information advises caution or avoidance of other medicines that are also known to potentially cause liver damage. Since some common over-the-counter pain relievers fall into this category, the potential for elevated risk means this combination warrants evaluation by a healthcare provider.


Q: How long does it usually take to feel the effects of Lizovag?

According to official pharmacokinetic studies, the active ingredient in Lizovag typically reaches its maximum concentration in the blood within approximately 1 to 2 hours after taking a single dose with a meal. However, the time it takes to see a therapeutic effect on the underlying condition may vary significantly depending on the infection being treated.


Q: Why does the packaging for Lizovag have a specific warning about certain activities?

The official safety profile for Lizovag includes common or less common side effects such as dizziness and asthenia, which is weakness or fatigue. Warnings on the packaging may relate to these effects, as they could potentially impact a patient’s ability to safely operate machinery or perform other tasks that require full alertness.


Q: Is there a generic version of Lizovag available?

Yes, the active ingredient in Lizovag is ketoconazole. This compound is the generic name and is available from various manufacturers.


Q: What should I do if the side effects of Lizovag feel too severe?

If serious symptoms such as unusual fatigue, loss of appetite, persistent nausea, jaundice (yellowing of the skin or eyes), dark urine, or pale stools occur, official labeling indicates that these serious symptoms warrant immediate reporting to a healthcare provider as they may be signs of serious liver injury (hepatotoxicity) associated with Lizovag use.


Q: Is Lizovag appropriate for older adults (seniors)?

Official regulatory guidance suggests that a maximum dose of 400 mg per day should not be exceeded in patients who may be susceptible to increased bone fragility, such as post-menopausal women and older adults. The regulatory guidance on maximum dose limits in this population is available for healthcare professionals.


Q: Is it okay to take Lizovag if I am taking over-the-counter supplements?

Lizovag is a strong enzyme inhibitor that can lead to potentially significant drug interactions. Regulatory documents include a requirement for patients to disclose all medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Q: Why is there a restriction on using Lizovag with certain blood pressure medicines?

Lizovag is a strong enzyme inhibitor, meaning it can slow down the body's clearance of many other drugs, including certain heart medications. This interaction can dangerously elevate the blood levels of the co-administered drug, potentially causing severe side effects like dangerous heart rhythm changes (QT prolongation). Official documents strictly contraindicate these combinations.


Q: Is it common for people to switch from a different drug to Lizovag?

According to the official prescribing information, due to its risk profile, oral Lizovag is generally restricted for use in patients who have failed or are intolerant to other effective antifungal therapies. Therefore, it is typically used after a different treatment has proven unsuccessful, rather than being the first choice.


Q: Does Lizovag change the way my body handles sugar (blood glucose)?

Lizovag is known to inhibit the metabolism of certain antidiabetic medicines via liver enzymes. This interaction could potentially raise the blood levels of those antidiabetic medicines, which may affect blood sugar control. The potential for this interaction is a factor for healthcare professionals to consider.


Q: Can Lizovag interact with herbal remedies, such as St. John's wort?

Yes, Lizovag is a strong enzyme inhibitor that can lead to potentially harmful interactions with many substances. Official regulatory documents require the disclosure of all supplements and herbal products, including St. John’s wort, for safety evaluation.


Q: How quickly does Lizovag leave the body after I stop taking it?

Official pharmacokinetic data indicates that the drug’s elimination from the blood plasma occurs in two phases. The half-life is approximately 2 hours for the first phase, followed by a slower phase with a half-life of about 8 hours.


Q: Can I take Lizovag if I am lactose intolerant?

According to the official documentation, the oral tablet formulation includes lactose monohydrate as an inactive ingredient. Patients should be aware of this official information regarding the drug’s composition.


Q: Is Lizovag considered a 'high alert' medication by any health organizations?

Due to the risk of potentially fatal liver injury, serious drug interactions, and adrenal gland problems, international health authorities have issued strong safety alerts and significant restrictions on the use of the oral form of Lizovag. This risk profile limits its role as a standard treatment.


Q: Does Lizovag interact with common cold or flu medications?

Common cold and flu medicines may contain ingredients that are metabolized by the same liver enzymes that Lizovag strongly inhibits, or they may carry their own risk of liver injury. Official labeling includes a requirement for patients to disclose all over-the-counter medications for safety evaluation before co-administering them.


Q: Is the packaged medicine considered a long-term treatment or is it short-term?

The oral form of Lizovag is generally limited to relatively short courses for specific, severe systemic fungal infections, rather than being a chronic treatment. This is due to its strong safety restrictions, which dictate it should only be used when alternative therapies are unavailable or not tolerated.


Q: Does Lizovag affect sleep patterns?

Official drug labels list asthenia (weakness or fatigue) as a common side effect of the medicine. This is a general side effect that may indirectly influence a patient’s overall energy level, potentially affecting their sleep or waking patterns.


Q: Are there any known food restrictions with Lizovag?

Official patient information indicates that the consumption of grapefruit or grapefruit juice is restricted while taking this medicine. Grapefruit can increase the level of the drug in the blood, which may raise the risk of experiencing side effects.


Q: What is the experience of people who have used Lizovag for a long time?

Official documents highlight that serious liver injury has been reported in patients receiving both short-term high doses and long-term low doses. Because of this, the regulatory label requires mandatory, frequent monitoring of liver function tests throughout the entire course of treatment, regardless of duration.


Q: Do studies support the use of Lizovag for its intended purpose?

Yes, the oral tablet is officially approved for the treatment of certain severe systemic fungal infections such as blastomycosis, coccidioidomycosis, and histoplasmosis. However, it is restricted for use only when other effective antifungal therapies are unavailable or not tolerated.


Q: What official health bodies (FDA, EMA) have approved Lizovag?

The active ingredient, ketoconazole, has been approved by the U.S. Food and Drug Administration (FDA) for specific uses. However, the European Medicines Agency (EMA) recommended the suspension of its marketing authorization for the oral treatment of fungal infections in Europe due to safety concerns.


Q: Does Lizovag cause 'brain fog' or affect concentration?

While the specific term 'brain fog' is not used in official documents, drug documentation does list dizziness and headache as common or less common side effects. These physical effects may result in a patient experiencing a feeling of reduced concentration or mental clarity.


Q: Can I use Lizovag if I am allergic to other similar drugs?

Lizovag is strictly forbidden (contraindicated) in patients with a known hypersensitivity to the drug itself. Because Lizovag belongs to the azole class of antifungals, cross-sensitivity to other similar medicines may be possible. This necessary disclosure is required for the healthcare provider to properly evaluate the risks of cross-sensitivity.


Q: Is Lizovag prescribed for conditions other than the main one listed?

The medication is strictly indicated for specific, severe systemic fungal infections such as blastomycosis. Regulatory documents specifically state the oral form is not indicated for common or minor conditions like onychomycosis, cutaneous dermatophyte, or common Candida infections.


Q: What information is available regarding Lizovag and pregnancy or breastfeeding?

Official regulatory documents advise that the drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The active ingredient can pass into breast milk, and official information describes a regulatory constraint on use during breastfeeding.

Advertisements

How should Lizovag be stored and disposed of?

Regulatory documents define the following official requirements for storing and disposing of Lizovag (Ketoconazole):

Storage Conditions

Requirement Details (Oral Tablets / Topical)
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Excursions permitted to 15 C to 30 C (59 F to 86 F).
Protection Keep the medicine dry, away from excess heat and moisture, and protected from light.
Prohibited Do not freeze (Topical formulations); storing above the stated temperature range is prohibited.
Container Keep the product in its original container, tightly closed. Oral tablets must be dispensed in a tight, light-resistant container.

Handling and Disposal Requirements

  • Child Protection: Keep this medication out of reach of children (and stored locked up, as specified in precautionary statements).
  • Environmental Disposal: Unused or expired medication should not be disposed of via wastewater or household waste due to environmental hazards (Very toxic to aquatic life).
  • Official Guidance: Dispose of contents/container in accordance with local/regional/national/international regulations. Consult a pharmacist for proper pharmaceutical take-back options.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lizovag found in:

A-Z Index: